BARDA Procures Regeneron's REGN-EB3 Investigational Ebola Treatment for National Preparedness
Go back to BARDA Procures Regeneron's REGN-EB3 Investigational Ebola Treatment for National Preparedness| Regeneron (NASDAQ: REGN) | Delayed: 796.02 -5.8 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $801.82 | 52 Week High | $592.36 | |||
| Open | $801.59 | 52 Week Low | $325.35 | |||
| Day High | $807.21 | P/E | 208.93 | |||
| Day Low | $789.39 | EPS | $3.81 | |||
| Volume | 602,604 | |||||
